A newly developed AI can predict which diseases specific genetic mutations are likely to cause, not just whether they are ...
Of women aged 40 years or older without breast cancer, 3% carry pathogenic variants in breast cancer risk genes — including many with no red flags in their family history.
More people under age 50 are developing cancer, and with that comes a shift in the model of care needed to serve this unique ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
A Missouri man was sentenced to 10 years in prison for orchestrating a Medicare fraud scheme that generated more than $174 million in genetic testing claims, according to a Dec. 12 news release from ...
This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
A doctor who authorized hundreds of cancer genetic tests at assisted living COVID-19 testing events has been sentenced to 7 years in prison.
A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a ...
UC San Diego researchers uncover enzyme behind cancer genome chaos, pointing to potential therapies for aggressive tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results